Home/ Supplements/ Lysine/ L-Lysine 500 mg

L-Lysine 500 mg

product on market Capsule NaturesPlus Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for L-Lysine 500 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
90
Servings
Amino acid/Protein
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

500 mg
Market median: 500.0mg (159 products)

Other Ingredients

Cellulose Microcrystalline Cellulose Magnesium Stearate
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: One capsule daily.

Warnings & Precautions

Keep out of reach of children.

Formulation Notes

Lysine is an essential amino acid required for building and maintaining the primary structural proteins collagen and elastin, which then form the foundations of all connective tissues such as skin, tendon and bone. Lysine is required for the production of all proteins and is a precursor to carnitine, needed for energy production and is a precursor to carnitine, needed for energy production and fat metabolism. In addition, lysine helps support healthy immune defenses and cardiovascular wellness.

Free from artificial colors and artificial preservatives. Free from all of the major allergens identified in the U.S. Food Allergen Labeling and Consumer Protection Act.

Vegetarian

Gluten Free

Free Form Amino Acid

Immune Support

Additional Information

Keep tightly closed in a cool, dry place.

Metadata

Product Details

UPC / SKU0 97467 05109 6
DSLD Entry Date2023-10-24
Product TypeAmino acid/Protein
FormCapsule
DSLD ID298336
Data Updated2026-04-11
Research

Research Evidence

3
Research Sources
74
Avg Quality
3
Meta Analysis
A Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2026 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
View all evidence for Lysine →
Compare

Similar Products

View all Lysine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.